These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23369416)

  • 21. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
    Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
    AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differences.
    Neumann T; Woiwod T; Neumann A; Ross B; Von Birgelen C; Volbracht L; Brockmeyer NH; Gerken G; Erbel R
    Eur J Med Res; 2004 Feb; 9(2):55-60. PubMed ID: 15090290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.
    Law MG; Friis-Møller N; El-Sadr WM; Weber R; Reiss P; D'Arminio Monforte A; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Kirk O; Sabin CA; Phillips AN; Lundgren JD;
    HIV Med; 2006 May; 7(4):218-30. PubMed ID: 16630034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and mid-term prognosis of acute coronary syndrome in HIV-infected patients on antiretroviral therapy.
    Boccara F; Ederhy S; Janower S; Benyounes N; Odi G; Cohen A
    HIV Med; 2005 Jul; 6(4):240-4. PubMed ID: 16011528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
    Rhee MS; Greenblatt DJ
    J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.
    Lipshultz SE; Mas CM; Henkel JM; Franco VI; Fisher SD; Miller TL
    Expert Rev Anti Infect Ther; 2012 Jun; 10(6):661-74. PubMed ID: 22734956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary heart disease in HIV-infected patients.
    Glesby MJ
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):68-73. PubMed ID: 16091251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV Infection and Myocardial Infarction.
    Calza L
    Curr HIV Res; 2016; 14(6):456-465. PubMed ID: 27492726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Increased cardiovascular risk in HIV patients].
    Wierema TK
    Ned Tijdschr Geneeskd; 2010; 154():A788. PubMed ID: 20456808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity.
    Jung O; Bickel M; Ditting T; Rickerts V; Welk T; Helm EB; Staszewski S; Geiger H
    Nephrol Dial Transplant; 2004 Sep; 19(9):2250-8. PubMed ID: 15238630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dyslipidemia related to antiretroviral therapy.
    Estrada V; Portilla J
    AIDS Rev; 2011; 13(1):49-56. PubMed ID: 21412389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abacavir exposure and cardiovascular risk factors in HIV-positive patients with coronary heart disease: a retrospective case-control study.
    Trevillyan JM; Cheng AC; Hoy J
    Sex Health; 2013 May; 10(2):97-101. PubMed ID: 23256968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV and cardiovascular risk factors.
    Falusi OM; Aberg JA
    AIDS Read; 2001 May; 11(5):263-8. PubMed ID: 11392695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination antiretroviral therapy and the risk of myocardial infarction.
    Friis-Møller N; Sabin CA; Weber R; d'Arminio Monforte A; El-Sadr WM; Reiss P; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD;
    N Engl J Med; 2003 Nov; 349(21):1993-2003. PubMed ID: 14627784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.
    Savès M; Chêne G; Ducimetière P; Leport C; Le Moal G; Amouyel P; Arveiler D; Ruidavets JB; Reynes J; Bingham A; Raffi F;
    Clin Infect Dis; 2003 Jul; 37(2):292-8. PubMed ID: 12856222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart failure in HIV infection: focus on the role of atherosclerosis.
    Ng B; MacPherson P; Haddad T; Dwivedi G
    Curr Opin Cardiol; 2014 Mar; 29(2):174-9. PubMed ID: 24406446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
    Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
    Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.